STAAR Surgical Co Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit
STAAR Surgical Co (STAA) reported Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit of $154.96 per share for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-02.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit · last filed 2023-08-02
- STAAR Surgical Co share-based payment arrangement, option, exercise price range, upper range limit for the quarter ending 2023-03-31 was $154.96, a 0.00% change year-over-year.
- STAAR Surgical Co share-based payment arrangement, option, exercise price range, upper range limit for the quarter ending 2022-04-01 was $154.96, a 45.49% increase year-over-year.
- STAAR Surgical Co share-based payment arrangement, option, exercise price range, upper range limit for the quarter ending 2021-04-02 was $106.51, a 142.95% increase year-over-year.
- STAAR Surgical Co share-based payment arrangement, option, exercise price range, upper range limit for the quarter ending 2020-04-03 was $43.84, a 0.00% change year-over-year.
- STAAR Surgical Co share-based payment arrangement, option, exercise price range, upper range limit for fiscal 2012 was $7.86.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 3 month | Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 6 month | Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 9 month | Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 12 month |
|---|---|---|---|---|
| 2023-06-30 | $154.96 10-Q · filed 2023-08-02 | |||
| 2023-03-31 | $154.96 10-Q · filed 2023-05-03 | |||
| 2022-09-30 | $154.96 10-Q · filed 2022-11-02 | |||
| 2022-07-01 | $154.96 10-Q · filed 2022-08-10 | |||
| 2022-04-01 | $154.96 10-Q · filed 2022-05-04 | |||
| 2021-10-01 | $154.96 10-Q · filed 2021-11-03 | |||
| 2021-07-02 | $154.96 10-Q · filed 2021-08-04 | |||
| 2021-04-02 | $106.51 10-Q · filed 2021-05-05 | |||
| 2020-10-02 | $51.42 10-Q · filed 2020-11-04 | |||
| 2020-07-03 | $43.84 10-Q · filed 2020-08-05 | |||
| 2020-04-03 | $43.84 10-Q · filed 2020-05-06 | |||
| 2019-09-27 | $43.84 10-Q · filed 2019-10-30 | |||
| 2019-06-28 | $43.84 10-Q · filed 2019-07-31 | |||
| 2019-03-29 | $43.84 10-Q · filed 2019-05-01 | |||
| 2012-12-28 | $7.86 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |